Evidence map›Paper›PMID 27401091›Full record

ArticleCell stress & chaperones2016

Utility of 17-(allylamino)-17-demethoxygeldanamycin treatment for skeletal muscle injury.

Cory W Baumann, Russell G Rogers, Jeffrey S Otis

Open access · bronzeAbstract read
In one paragraph

Article in Cell stress & chaperones, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. CORP: In vivo muscle strength-perspectives on the design and interpretation of preclinical animal studies.American journal of physiology. Regulatory, integrative and comparative physiology · 2025
    Review
  3. Traumatic Skeletal Muscle Injury and Recovery.Advances in experimental medicine and biology · 2025
    Review
  4. Article
  5. Adaptability to eccentric exercise training is diminished with age in female mice.Journal of applied physiology (Bethesda, Md. : 1985) · 2023
    Article
  6. Mechanisms of weakness in Mdx muscle following in vivo eccentric contractions.Journal of muscle research and cell motility · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. BGP-15 improves contractile function of regenerating soleus muscle.Journal of muscle research and cell motility · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Cory W BaumannDepartment of Physical Medicine and Rehabilitation, University of Minnesota Medical School, Minneapolis, MN, USA. cbaumann@umn.edu.
Russell G RogersDepartment of Kinesiology and Health, Georgia State University, Atlanta, GA, USA.
Jeffrey S OtisDepartment of Kinesiology and Health, Georgia State University, Atlanta, GA, USA.
Georgia State University · USUniversity of Minnesota Medical Center · US

Funding

Training Grant: Functional Proteomics of AgingT32AG029796 · NIA · UNIVERSITY OF MINNESOTA · PI EDGAR A ARRIAGA, Douglas G Mashek · 2008 to 2026
$6.6M
NIA NIH HHS T32 AG029796
6 · The paper itself

Abstract

Repeated eccentric contractions can injure skeletal muscle and result in functional deficits that take several weeks to fully recover. The 70-kDa heat shock protein (Hsp70) is a stress-inducible molecular chaperone that maintains protein quality and plays an integral role in the muscle's repair processes following injury. Here, we attempted to hasten this recovery by pharmacologically inducing Hsp70 expression in mouse skeletal muscle with 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) (40 mg/kg) both prior to and throughout the first 7 days after an injurious bout of 150 maximal eccentric contractions. Hsp70 content in the injured skeletal muscle was strongly induced following the eccentric contractions and remained elevated over the next 7 days as the muscle underwent repair. Treatment with 17-AAG increased Hsp70 content ∼fivefold; however, this was significantly less than that induced by the injury. Moreover, 17-AAG treatment did not recover the decrements to in vivo isometric torque production following the bout of eccentric contractions. Together, these findings demonstrate that although Hsp70 content was induced in the uninjured skeletal muscle, treatment of 17-AAG (40 mg/kg) was not a preventive measure to either reduce the severity of skeletal muscle damage or enhance functional recovery following a bout of maximal eccentric contractions.

Indexed as

AnimalsBenzoquinonesHSP70 Heat-Shock ProteinsLactams, MacrocyclicMaleMiceMice, Inbred C57BLMuscle ContractionMuscle, SkeletalMuscular DiseasesUp-RegulationBenzoquinonesHSP70 Heat-Shock ProteinsLactams, MacrocyclictanespimycinChaperonesDamageEccentric contractionsIsometric torqueMouse model

Identifiers

PMID27401091
PMCPMC5083665
OpenAlexW2461387438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.